Integrated BioPharma Inc (INBP) stock
INBPOTCPharmaceutical PreparationsFiscal year ends June 30
$0.18+0.00 (0.00%)
Close on Oct 19, 2026Market cap $5.59MP/E –Yield –
Integrated BioPharma cash
Cash and short-term investments held at the end of each period.
Integrated BioPharma's cash was $4.47M at Jun 30, 2026. For fiscal 2026 it was $4.47M, up 23.7% from the year before. Over ten years it grew 27.5% a year on average. The highest annual figure on record is $4.47M in fiscal 2026.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $4.47M | +23.7% |
| FY2025 | Jun 30, 2025 | $3.62M | +115.6% |
| FY2024 | Jun 30, 2024 | $1.68M | +27.4% |
| FY2023 | Jun 30, 2023 | $1.32M | +297.6% |
| FY2022 | Jun 30, 2022 | $331.00K | +57.6% |
| FY2021 | Jun 30, 2021 | $210.00K | -47.8% |
| FY2020 | Jun 30, 2020 | $402.00K | -15.4% |
| FY2019 | Jun 30, 2019 | $475.00K | +108.3% |
| FY2018 | Jun 30, 2018 | $228.00K | +72.7% |
| FY2017 | Jun 30, 2017 | $132.00K | -66.6% |
| FY2016 | Jun 30, 2016 | $395.00K | +456.3% |
| FY2015 | Jun 30, 2015 | $71.00K | -84.3% |
| FY2014 | Jun 30, 2014 | $451.00K | +720.0% |
| FY2013 | Jun 30, 2013 | $55.00K | -62.1% |
| FY2012 | Jun 30, 2012 | $145.00K | -80.0% |
| FY2011 | Jun 30, 2011 | $725.00K | +12.1% |
| FY2010 | Jun 30, 2010 | $647.00K | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $4.47M | +23.7% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $5.83M | +96.8% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $5.31M | +115.9% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $4.73M | +108.4% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $3.62M | +115.6% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $2.96M | +46.6% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $2.46M | +236.2% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $2.27M | -12.5% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $1.68M | +27.4% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $2.02M | -20.1% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $732.00K | -32.5% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $2.59M | +122.1% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $1.32M | +297.6% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $2.53M | +858.0% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $1.09M | +569.8% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $1.17M | +1949.1% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $331.00K | +57.6% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $264.00K | +151.4% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $162.00K | +276.7% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $57.00K | -84.6% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $210.00K | -47.8% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $105.00K | -81.4% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $43.00K | -35.8% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $369.00K | -29.7% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $402.00K | -15.4% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $565.00K | +31.1% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $67.00K | +48.9% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $525.00K | +43.8% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $475.00K | +108.3% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $431.00K | +595.2% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $45.00K | -16.7% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $365.00K | +28.5% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $228.00K | +72.7% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $62.00K | -68.4% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $54.00K | -18.2% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $284.00K | +208.7% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $132.00K | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $196.00K | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $66.00K | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $92.00K | – |
See a number that looks wrong?